Stocks and Investing
Stocks and Investing
Fri, June 2, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, June 1, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Brian Cheng Downgraded (ACET) to Hold and Decreased Target to $6 on, Jun 1st, 2023
Brian Cheng of JP Morgan, Downgraded "Adicet Bio, Inc." (ACET) to Hold and Decreased Target from $20 to $6 on, Jun 1st, 2023.
Brian has made no other calls on ACET in the last 4 months.
There are 3 other peers that have a rating on ACET. Out of the 3 peers that are also analyzing ACET, 0 agree with Brian's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Brian
- Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $19 on, Monday, May 15th, 2023
- Robert Driscoll of "Wedbush" Reiterated at Buy and Held Target at $30 on, Wednesday, May 10th, 2023
- Edward White of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $38 on, Wednesday, May 10th, 2023
Contributing Sources